Skip to main content

Table 1 Summary of KLA patients

From: Sirolimus in the treatment of kaposiform lymphangiomatosis

N

Age at start /sex

Location of target lesions

Major signs, symptoms, and/or complications

Previous treatments

Duration of sirolimus treatment (months)

Range (mean) of trough concentrations (ng/mL)

Response to sirolimus

1a

2 years/M

Mediastinum, abdominal cavity, pelvic cavity, bilateral inguinal regions and testes

Abdominal distention, pain and coagulation disorder

Corticosteroid, immune globulin and platelet transfusion

6

7.8–12.7 (10.4)

PD

2a

4 months/F

Left mediastinum and left lung

Dyspnea pleural effusion and coagulation disorder

Thoracic drainage

18

6.1–15.7 (10.2)

PR

3a

5 years/M

Lungs, vertebrae, ribs and mediastinum

Pleural effusion and coagulation disorder

Thoracic drainage, fibrinogen transfusion, exploratory thoracotomy

42

10.7–14.9 (13.3)

PR

4a

6 months/M

Lungs, mediastinum, spleen, liver, pancreas and mesentery

Abdominal distention, vomiting and coagulation disorder

Vincristine plus corticosteroid, aspirin

41

5.1–13.7 (11.6)

SD

5a

14 months/M

Lungs and spleen

Cough, respiratory distress, pleural effusion, pericardial effusion and coagulation disorder

Pericardiocentesis, corticosteroid, splenectomy and platelet transfusion

14

5.9–14.3 (12.1)

PR

6a

4 years/M

Left lung and mediastinum

Cough and coagulation disorder

Sirolimus, sirolimus plus steroids, sirolimus and vincristine

21

9.4–15.8 (10.6)

SD

7a

2 years/M

Mediastinum, lungs, neck and spleen

Dyspnea, cough and coagulation disorder

Propranolol and prednisone

21

10.0–14.7 (13.2)

SD

8b

8 years/M

Bone, thoracic and mediastinal

Chylothorax and coagulation disorder

Interferon and propranolol

30 (cessation)

4.4–9.0 (7.5)

PR

9b

8 years/M

Bone, thoracic and mediastinal

Scoliosis, chylothorax and coagulation disorder

Steroids and propranolol

24

8.1–12.4 (11.2)

SD

10b

20 years/M

Bone, thoracic and right chest wall

Gastrointestinal hemorrhage and coagulation disorder

Steroids

12

4.7–6.0 (5.5)

PR

11b

–/M

Thorax

NG

NG

NG

NG

PD

12b

7 years/M

Left scapular, left arm and thoracic vertebral bodies

Dyspnea, shortness of breath, pleural effusion and coagulation disorder

Chinese traditional medicine, pleurocentesis and albumin

8

9.3–13.4 (12.3)

PR

13b

NG

NG

NG

NG

12

10.0–15.0 (NG)

PR

14b

NG

NG

NG

NG

12

10.0–15.0 (NG)

PR

15b

NG

NG

NG

NG

12

10.0–15.0 (NG)

PR

16b

NG

NG

NG

NG

12

10.0–15.0 (NG)

PR

17b

NG

NG

NG

NG

12

10.0–15.0 (NG)

PR

18b

NG

NG

NG

NG

12

10.0–15.0 (NG)

PR

19b

NG

NG

NG

NG

12

10.0–15.0 (NG)

PD

20b

7 years/M

Abdominal cavity, lower neck, mediastinum, bone and left upper arm

Cephalohematoma and coagulation disorder

Steroids, vincristine and zoledronate

12

9.4–14.8 (NG)

PR

21b

13 years/F

Bone, mediastinum, spleen

Cough, fever, fatigue, intermittent wheezing, pleural effusion and coagulation disorder

Thoracostomy

3

NG

PR

22b

20 months/M

Mediastinum and spleen

Cough, pleural effusion, pericardial effusion, epidural hematoma and coagulation disorder

Diaphragmatic fenestrations

7

NG

PD

23b

11 years/F

Mediastinum, bone and spleen

Cough, chest pain, fatigue, listlessness, weight loss, coagulation disorder and pericardial effusion, coagulation disorder

Pericardiocentesis

31

NG

SD

24b

4 years/M

Bone, spleen and mediastinum

Fatigue, decreased appetite, weight loss, cough, spontaneous bruising, back pain, coagulation disorder and pleural effusion

Cryoprecipitate, platelet infusions and prednisolone

NG

NG

SD

  1. M male, F female, NG not given, PD progressive disease, PR partial response, SD stable disease
  2. aData from our center
  3. bData from literature